欧洲呼吸学会儿童和青少年支气管扩张症管理指南
欧洲呼吸学会(ERS)工作组采用ERS标准化方法,包括系统文献综述和GRADE方法,制定儿童和青少年支气管扩张症管理指南。多学科团队提出14个关键临床问题(7个PICO和7个叙述性问题),涵盖定义、诊断、急性加重抗生素治疗、病原体清除、长期抗生素、哮喘型治疗、黏液活性药物、气道清除、病因检查、疾病监测、手术前考虑因素及可逆性与预防。
要点
- 指南涵盖儿童/青少年支气管扩张症的定义、诊断方法与急性加重抗生素治疗。
- 涉及病原体清除、长期抗生素治疗、哮喘型治疗(吸入激素和支气管扩张剂)及黏液活性药物。
- 包括气道清除、病因检查、疾病监测、手术前考虑因素及可逆性与预防。
英文原文(摘要)· 点击展开
There is increasing awareness of bronchiectasis in children and adolescents, a chronic pulmonary disorder associated with poor quality of life for the child/adolescent and their parents, recurrent exacerbations, and costs to the family and health systems. Optimal treatment improves clinical outcomes. Several national guidelines exist, but there are no international guidelines.The European Respiratory Society (ERS) Task Force for the management of paediatric bronchiectasis sought to identify evidence-based management (investigation and treatment) strategies. It used the ERS standardised methodology that included a systematic review of the literature and application of the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to define the quality of the evidence and level of recommendations.A multidisciplinary team of specialists in paediatric and adult respiratory medicine, infectious disease, physiotherapy, primary care, nursing, radiology, immunology, methodology, patient advocacy and parents of children/adolescents with bronchiectasis considered the most relevant clinical questions (for both clinicians and patients) related to managing paediatric bronchiectasis. 14 key clinical questions (seven PICO (Patient, Intervention, Comparison, Outcome) and seven narrative) were generated. The outcomes for each PICO were decided by voting by the panel and parent/patient advisory group.This guideline addresses the definition, diagnostic approach and antibiotic treatment of exacerbations, pathogen eradication, long-term antibiotic therapy, asthma-type therapies (inhaled corticosteroids and bronchodilators), mucoactive drugs, airway clearance, investigation of underlying causes of bronchiectasis, disease monitoring, factors to consider before surgical treatment, and the reversibility and prevention of bronchiectasis in children/adolescents. Benchmarking quality of care for children/adolescents with bronchiectasis to improve clinical outcomes and evidence gaps for future research could be based on these recommendations.
引用
- Chang AB, Fortescue R, Grimwood K, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J. 2021. PMID: 33542057. doi:10.1183/13993003.02990-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。